4577 — Daito Pharmaceutical Share News
0.000.00%
Last trade - 00:00Table: Daito Pharmaceutical -Q1 group results
Execution Of JV And Share Transfer Agreement For Transfer Of Kyorin Pharmaceutical's Generic Drug Business To JV By Daito, Meiji Seika Pharma And Dbj
Table: Daito -2025/26 parent results
Table: Daito -2025/26 group results
Table: Daito - 9-MTH group results
Table: Daito - 6-MTH group results
To Buy Back Up To 3.3% Of Own Shares Worth 1.5 Billion Yen
Table: Daito -Q1 group results
Table: Daito -2024/25 parent results
Table: Daito -2024/25 group results
Table: Daito - 9-MTH group results
To Conduct 2-For-1 Stock Split For Shareholders As Of May 31
Table: Daito - 6-MTH group results
Table: Daito -Q1 group results
To Retire Treasury Shares Worth 2.23% Of Outstanding Stock On July 31
Table: Daito -2023/24 group results
Table: Daito -2023/24 group forecast
Brief: Daito Pharmaceutical Co Ltd Says To Buy Back Up To 2.2% Of Own Shares Worth 1 Billion Yen
Table: Daito - 9-MTH group results